Biological markers in Alzheimer disease

Neurobiology of Aging

Volumn 24, Issue 1, 2003, Pages 191-193

  Ferrarese, Carlo ^a   Di Luca, Monica ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Alzheimer disease; Amyloid precursor protein; Biological markers; Caveolin; Chemokines; Cytokines; Excitotoxicity; Fibroblasts; Glutamate; Inflammation; Mitochondrial DNA; Oxidative stress; Platelets

Indexed keywords

AMYLOID; BIOLOGICAL MARKER; CLIOQUINOL;

ALZHEIMER DISEASE; CONFERENCE PAPER; FIBROBLAST; ITALY; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCALE UP; TRANSGENIC MOUSE; UNITED STATES;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; HUMANS; INFORMATION SERVICES;

EID: 0037213403     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00051-9     Document Type: Conference Paper

References (13)

1. Cherny R., Atwood C., Xilinas M., Gray D., Jones W., McLean C.et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 30:2001;665-676.
2. Del Bo R., Comi G.P., Perini M.P., Strazzer S., Bresolin N., Scarlato G. Down's syndrome fibroblasts anticipate the accumulation of specific aging-related mtDNA mutations. Ann. Neurol. 49:2001;137-168.
3. De Luigi A., Fragiacomo C., Lucca U., Quadri P., Tettamanti M., De Simoni M.G. Inflammatory markers in Alzheimer's disease and multi-infarct dementia. Mech. Aging Dev. 122/16:2001;1985-1995.
4. Facheris M, Galbusera C, Magni F, Begni B, Galimberti G, Zoia C, et al. Increased lipid peroxidation in plasma from Alzheimer disease and mild cognitive impairment patients. Abstract book V Scientific Meeting ITINAD Roma, 2001. p. 64.
5. Ferrarese C., Zoia C., Pecora N., Piolti R., Frigo M., Bianchi G.et al. Reduced platelet glutamate uptake in Parkinson's disease. J. Neural Transm. 106:1999;685-692.
6. Ferrarese C., Begni B., Canevari C., Zoia C., Piolti R., Frigo M.et al. Glutamate uptake is decreased in platelets from Alzheimer patients. Ann. Neurol. 47:2000;641-643.
7. Ferrarese C., Sala G., Riva R., Begni B., Zoia C., Tremolizzo L.et al. Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology. 56:2001;270-272.
8. Galimberti G, Sala G, Canevari C, Agazzi C, Raggi ME, Ferrarese C. Cytokine release from peripheral blood cells of Alzheimer (AD) and mild cognitive impairment (MCI) patients. Abstract book V Scientific Meeting ITINAD Roma, 2001. p. 67.
9. Galli Kienle M, Ferrarese C, Begni B, Zoia C, Brighina L, Cattaneo A, et al. Adducts of A peptides with hydroxynonenal as possible early markers of Alzheimer's disease. In: Proceedings of the 42nd International Conference on the Bioscience of Lipids, Bergen, Norvegia. Chem. Phys. Lipids 2001;110:144.
10. Licastro F., Pedrini S., Caputo L., Annoni G., Davis L.J., Ferri C.et al. Increased plasma levels of interleukin-1, interleukin-6 and a-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J. Neuroimmunol. 103:2000;97-102.
11. Padovani A., Pastorino L., Borroni B., Colciaghi F., Rozzini L., Monastero R.et al. Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology. 57:2001;2243-2248.
12. Padovani A., Borroni B., Colciaghi F., Pettenati C., Cottini E., Agosti C.et al. Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch. Neurol. 59:2002;71-75.
13. Pitto M., Ravasi D., Raimondo F., Guzzi F., Masserini M. Studies on the caveolar localization of amyloid precursor protein in human cultured fibroblasts. J. Neurochem. 77(1):2001;24.